Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
52.70
-0.97 (-1.81%)
Mar 11, 2026, 9:53 AM EDT - Market open
Supernus Pharmaceuticals Employees
Supernus Pharmaceuticals had 778 employees as of December 31, 2025. The number of employees increased by 104 or 15.43% compared to the previous year.
Employees
778
Change (1Y)
104
Growth (1Y)
15.43%
Revenue / Employee
$924,103
Profits / Employee
-$49,550
Market Cap
3.03B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 778 | 104 | 15.43% |
| Dec 31, 2024 | 674 | 22 | 3.37% |
| Dec 31, 2023 | 652 | 40 | 6.54% |
| Dec 31, 2022 | 612 | 37 | 6.43% |
| Dec 31, 2021 | 575 | 12 | 2.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Amneal Pharmaceuticals | 8,700 |
| Phibro Animal Health | 2,475 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| HUTCHMED (China) | 1,780 |
| Lantheus Holdings | 1,193 |
| Prestige Consumer Healthcare | 600 |
SUPN News
- 14 days ago - Supernus Pharmaceuticals, Inc. (SUPN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 15 days ago - Supernus Pharmaceuticals to Participate in March Investor Conferences - GlobeNewsWire
- 26 days ago - Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026 - GlobeNewsWire
- 4 weeks ago - Lunai Bioworks, Inc. Issues Letter to Shareholders - PRNewsWire
- 5 weeks ago - Supernus: Outlook For 2026 Positive, Upholding Buy Rating - Seeking Alpha
- 7 weeks ago - These under-the-radar stocks combine fast growth with big upside potential - Market Watch
- 3 months ago - Supernus Pharmaceuticals, Inc. (SUPN) Presents at BofA Securities CNS Therapeutics Virtual Conference 2025 Transcript - Seeking Alpha